Hyodeoxycholic Acid

Star0

DB11789InvestigationalSmall molecule

Hyodeoxycholic Acid has been used in trials studying the treatment of Hypercholesterolemia.

Mechanism: Pharmacologically active on Oxysterols receptor LXR-beta and Oxysterols receptor LXR-alpha
Curator reviewed
Formula / weight: C₂₄H₄₀O₄ · 392.58 g/mol (avg)
Code names: AHRO-001

Resolves to

Compound

UNII7A33Y6EHYKCAS83-49-8ChEMBLCHEMBL272621ChEBI52023PubChem5283820

Structure

InChIKeyDGABKXLVXPYZII-SIBKNCMHSA-NSMILES[H][C@@]1(CC[C@@]2([H])[C@]3([H])C[C@H](O)[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O

Targets

P55055NR1H2Q13133NR1H3

What you can answer from here — as of August 30, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

176Drug interactionsStructured to mechanism, not free text

1Clinical trialPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Hyodeoxycholic Acid, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account